VASOACTIVE PEPTIDE INHIBITION
Certain known hydroxamic acid derivatives and their salts are useful as inhibitors of the conversion of Big Endothelin to Endothelin by a putative endothelin converting enzyme, and are useful in the management of diseases mediated by overproduction of, or over-responsiveness to, endothelin in mammal...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
14.04.1994
|
Edition | 5 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Certain known hydroxamic acid derivatives and their salts are useful as inhibitors of the conversion of Big Endothelin to Endothelin by a putative endothelin converting enzyme, and are useful in the management of diseases mediated by overproduction of, or over-responsiveness to, endothelin in mammals. Examples of such compounds are (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-L-phenylalanine; (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-4-(oxymethylenecarboxyethyl)-L-phenylalanine-N-methylamide; (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-4-(oxymethylenecarboxamido)-L-phenylalanine-N-methylamide; and (4-(N-Hydroxyamino)-2R-isopropylsuccinyl)-L-phenylalanine.
Certains dérivés d'acide hydroxamique connus et leurs sels sont utiles en tant qu'inhibiteurs de la conversion de l'endothéline Big en endothéline par un enzyme de conversion de l'endothéline putatif, et le traitement de maladies dues à la surproduction d'endothéline ou à la réponse exagérée à l'endothéline chez les mammifères. Les composés utilisés peuvent être de la [4-(N-Hydroxyamino)-2R-isobutylsuccinyl]-L-phénylalanine; du [4-(N-Hydroxyamino)-2R-isobutylsuccinyl]-4-(oxyméthylènecarboxyéthyl)-L-phénylalanine-N-méthylamide; un [4-(N-hydroxyamino)-2R-isobutylsuccinyl]-4-(oxyméthylènecarboxamido)-L-phénylalanine-N-méthylamide; et de la [4-(N-hydroxyamino)-2R-isopropylsuccinyl]-L-phénylalanine. |
---|---|
AbstractList | Certain known hydroxamic acid derivatives and their salts are useful as inhibitors of the conversion of Big Endothelin to Endothelin by a putative endothelin converting enzyme, and are useful in the management of diseases mediated by overproduction of, or over-responsiveness to, endothelin in mammals. Examples of such compounds are (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-L-phenylalanine; (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-4-(oxymethylenecarboxyethyl)-L-phenylalanine-N-methylamide; (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-4-(oxymethylenecarboxamido)-L-phenylalanine-N-methylamide; and (4-(N-Hydroxyamino)-2R-isopropylsuccinyl)-L-phenylalanine.
Certains dérivés d'acide hydroxamique connus et leurs sels sont utiles en tant qu'inhibiteurs de la conversion de l'endothéline Big en endothéline par un enzyme de conversion de l'endothéline putatif, et le traitement de maladies dues à la surproduction d'endothéline ou à la réponse exagérée à l'endothéline chez les mammifères. Les composés utilisés peuvent être de la [4-(N-Hydroxyamino)-2R-isobutylsuccinyl]-L-phénylalanine; du [4-(N-Hydroxyamino)-2R-isobutylsuccinyl]-4-(oxyméthylènecarboxyéthyl)-L-phénylalanine-N-méthylamide; un [4-(N-hydroxyamino)-2R-isobutylsuccinyl]-4-(oxyméthylènecarboxamido)-L-phénylalanine-N-méthylamide; et de la [4-(N-hydroxyamino)-2R-isopropylsuccinyl]-L-phénylalanine. |
Author | CRIMMIN, MICHAEL, JOHN BONE, ELISABETH, ANN WOOD, LARS, MICHAEL |
Author_xml | – fullname: BONE, ELISABETH, ANN – fullname: WOOD, LARS, MICHAEL – fullname: CRIMMIN, MICHAEL, JOHN |
BookMark | eNrjYmDJy89L5WSQDXMM9nd0DvEMc1UIcA0I8XRxVfD08_B08gzx9PfjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXx4f6WJgbmpkbmjkbGRCgBADk_Ir8 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | INHIBITION DES PEPTIDES VASOACTIFS |
Edition | 5 |
ExternalDocumentID | WO9407527A2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO9407527A23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 11:22:44 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO9407527A23 |
Notes | Application Number: WO1993GB02044 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19940414&DB=EPODOC&CC=WO&NR=9407527A2 |
ParticipantIDs | epo_espacenet_WO9407527A2 |
PublicationCentury | 1900 |
PublicationDate | 19940414 |
PublicationDateYYYYMMDD | 1994-04-14 |
PublicationDate_xml | – month: 04 year: 1994 text: 19940414 day: 14 |
PublicationDecade | 1990 |
PublicationYear | 1994 |
RelatedCompanies | BRITISH BIO-TECHNOLOGY LIMITED |
RelatedCompanies_xml | – name: BRITISH BIO-TECHNOLOGY LIMITED |
Score | 2.4343688 |
Snippet | Certain known hydroxamic acid derivatives and their salts are useful as inhibitors of the conversion of Big Endothelin to Endothelin by a putative endothelin... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | VASOACTIVE PEPTIDE INHIBITION |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19940414&DB=EPODOC&locale=&CC=WO&NR=9407527A2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFH9ZplFvOjVOneFguBGBtWM7EDOgBEwGRBF3WyiFZJdtcRj_fV-RTS96a9rk9SN53-_3CnA_nFAudGFqo7FMM9IJ11DpcY3morJkv7S8wVfMolHwSp7mdN6B5Q4L0_QJ_WyaIyJHFcjvdSOvNz9BLK-prdw-8CVOrR_91PZU0cLFiE4MonqOzZLYi13VddFvU6NnG1csalpTlNYHaEVbkhlY5khQyua3RvFP4TBBYqv6DDrlqgfH7u7jtR4czdp8Nw5b1tuewyCbvsSy5CNjSsKSNPSYEkZB6IQyyHQBis9SN9Bwn8X-Tou3eH-i4SV00dUvr0AZC71EA6IqqVmhJcVzQ3CBBk0xKXhOraIP_T_JXP-zdgMn3z2AiWaQW-jW7x_lAJVpze-aZ_gCsKx1vg |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjVWrXIw3IhAd0s5EFNeAS2PKGJvhGUh6aU2FuPfd8C2etHbZjeZfSTznm8W4HakU8ZlrkrjSZNmpDqTUOkxiea80pp-aXmLrwjCsfdCHuZ03oHFFgvT9gn9bJsjIkcVyO91K69XP0Esu62tXN-xBU693buJYYt8AxcjMlGIaJuGE0d2ZImWhX6bGD4ZuKJRVZuitN5DC1trmMFJzQaUsvqtUdwj2I-R2LI-hk657EPP2n681oeDYJPvxuGG9dYnMEynz1FT8pE6QuzEiW87gh96vuk3QaZTEFwnsTwJ98l2d8peo92JRmfQRVe_PAdhwuUSDYiqpGqFlhTLFc44GjSFXrCcasUABn-Sufhn7QZ6XhLMspkfPl7C4Xc_YCIp5Aq69ftHOUTFWrPr9km-AF_7eLE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=VASOACTIVE+PEPTIDE+INHIBITION&rft.inventor=BONE%2C+ELISABETH%2C+ANN&rft.inventor=WOOD%2C+LARS%2C+MICHAEL&rft.inventor=CRIMMIN%2C+MICHAEL%2C+JOHN&rft.date=1994-04-14&rft.externalDBID=A2&rft.externalDocID=WO9407527A2 |